So, we went to investigate whether the activity of tumorigenic signaling pathways in LN-18 GBM cells, affected by the presence of SRGN, such as TGFβRI and CXCR-2, are involved in the activation of fibroblasts. This evidence concerns the gene CXCR2 and glioblastoma.